All News

State and local marijuana laws continue to evolve toward legalization much faster than the scientific community can collect the data to help society weigh the health, safety, and ethical ramifications of these new laws.

It will likely take decades to determine the long-term effects of cannabis, according to a session presented at the American College of Rheumatology Annual Meeting.

Growing evidence suggests immune deficiencies in the central nervous system are involved with Alzheimer’s disease.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Providing web-based vaccine information with social media components during pregnancy can allay concerns about childhood vaccination.

Nucala is an interleukin-5 antagonist under consideration as an add-on maintenance therapy for certain patients with chronic obstructive pulmonary disease.

Ferric citrate was originally approved for the control of serum phosphorus levels in patients with chronic kidney disease who require dialysis.

Canagliflozin (Invokana, Janssen) improved renal outcomes and demonstrated potential renal protective effects, according to additional analyses from the CANVAS clinical trial presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting.

Biosimilars have yet to make a significant impact on the prescription drug market.

Drug patent expirations may cause a significant shift in the pharmacy benefits marketplace.

The findings demonstrated that female gender, older age, and Caucasian race were the most likely predictors of opioid use in patients with JFMS.

Patients with rheumatoid arthritis (RA) who took biologics or triple therapy had a longer fail time than patients who took methotrexate oral monotherapy, suggesting that these treatments may be a good follow-up to failed first-line methotrexate treatment.

Changes to the rules are expected to reduce physician burden and foster innovation in healthcare.

Mortality related to liver cirrhosis outpaces the rate for lung, colorectal, stomach, liver, and breast cancers.

New findings may result in a better treatment against Parkinson’s disease.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Exercise found to be one of the most important approaches for self-managing the consequences of multiple sclerosis.

Patients with hepatitis C who achieved sustained virologic response with a direct-acting antiviral maintained health improvements that enhanced their long-term quality of life.

Alectinib (Alecensa) found to significantly improve progression-free survival among patients with lung cancer.

Alectinib (Alecensa) found to reduce the risk of disease progression in patients with metastatic non-small cell lung cancer.

Some pharma executives welcome a disruption to the current pharmacy benefits management system.

Amazon entering pharmacy may transform pharmacy benefit managers.

Rigorous screening guidelines can reduce the number of undiagnosed cases of diabetes.

Only 1% of women aged 20 to 68 years had an oral HPV infection.

Vemurafenib is a kinase inhibitor indicated to treat patients with Erdheim-Chester disease with BRAF V600 mutations.